Atlantic Cancer Consortium leadership and members share updates with the Network

On Thursday, November 20, leadership and researchers from the Atlantic Cancer Consortium presented their work to Network members as part of the MOHCCN seminar series. 

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by Natalie A-K, MBA, CPA-CMA, de novo stage 4 breast cancer patient and MOHCCN Patient Working Group and Network Council member, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, TFRI.

Watch the full video

Speakers

Consortium Activities Update

Robin Urquhart, PhD - Associate Professor, Canadian Cancer Society (Nova Scotia Division) Endowed Chair in Population Cancer Research, Dalhousie University; Senior Scientist, Beatrice Hunter Cancer Research Institute; Affiliate Scientist, Nova Scotia Health Authority; MOHCCN consortium lead (ACC)

Research Presentations

Myeloma research in the Atlantic Cancer Consortium

Anthony Reiman, MD, SM, FRCPC - Medical oncologist, Saint John Regional Hospital; Professor, School of Integrated Health, University of New Brunswick; Professor, Department of Medicine, Dalhousie University; Senior Scientist, Beatrice Hunter Cancer Research Institute

• View scientific and plain language abstracts

Refined ChIP-seq protocol for high-quality chromatin profiling in solid tissues using the Complete Genomics/MGI sequencing platform

Hayley Alloway, PhD - Postdoctoral research fellow, Benoukraf laboratory, Division of Biomedical Sciences, Memorial University of Newfoundland

• View scientific and plain language abstracts